Cholesterol News and Research

RSS

Cholesterol is a waxy, fat-like substance made in the liver, and found in the blood and in all cells of the body. Cholesterol is important for good health and is needed for making cell walls, tissues, hormones, vitamin D, and bile acid.

Zetia co-administered with Fenofibrate significantly reduced LDL ("bad") cholesterol in mixed hyperlipidemia patients

Results from a new study showed that coadministration of Zetia (ezetimibe) and fenofibrate significantly reduced LDL ("bad") cholesterol (LDL-C), non-high density lipoprotein cholesterol (non-HDL-C) and apo B1 in patients with mixed hyperlipidemia and high LDL cholesterol when compared to fenofibrate alone.

9 Nov 2004

FDA has warned consumers not to purchase or to consume Actra-Rx or Yilishen, promoted as "dietary supplements" for treating erectile dysfunction

The Food and Drug Administration today warned consumers not to purchase or to consume Actra-Rx or Yilishen, two products promoted and offered for sale on Web sites as "dietary supplements" for treating erectile dysfunction and enhancing sexual performance for men.

9 Nov 2004

Cranberry juice may help prevent gum disease

New research presented at a recent symposium suggests that cranberry juice may help prevent certain oral health problems, including diseases of the gums and teeth.

9 Nov 2004

ACE inhibitors not needed for many heart disease patients

Many heart disease patients who are already receiving state-of-the-art therapy do not benefit from additional treatment with angiotensin converting enzyme (ACE) inhibitors, according to results of a new study funded by the National Heart, Lung, and Blood Institute (NHLBI).

8 Nov 2004

Generic statin drugs shown to produce similar or better results than expensive brand-name drugs

Researchers from Kaiser Permanente's Northern California region are presenting a study at this week's American Heart Association Scientific Sessions showing that patients who use a generic statin drug rather than its brand-name equivalent fared as well as- sometimes better than-patients on the more expensive drug.

8 Nov 2004

Walnut supplementation favorably affects cholesterol and other lipids that are signs of cardiovascular risk

A Penn State study has shown that a diet rich in alpha-linolenic acid from walnuts, walnut oil and flaxseed oil not only lowered bad cholesterol but also decreased markers for blood vessel inflammation in men and women representative of typical Americans at cardiovascular risk.

8 Nov 2004

Lipid Sciences' selective delipidation process demonstrates enhanced ability in removing cholesterol from cells

Lipid Sciences announced today that researchers have successfully used the Company's proprietary "selective delipidation" process to create a modified form of HDL ("good cholesterol") that is known to be more effective in reverse cholesterol transport, the body's natural process for removing lipids from arterial plaque.

8 Nov 2004

Technology to determine a patient's response to aspirin therapy taken to prevent heart attacks

This technology has demonstrated the ability to assess an individual's relative risk for heart attack by measuring the person's degree of aspirin resistance.

8 Nov 2004

Association between long-term air pollution exposure and the early stages of atherosclerosis

Air pollution may trigger and accelerate narrowing of carotid arteries, according to a study presented at the American Heart Association's Scientific Sessions 2004.

8 Nov 2004

Obese and overweight men spend 3.5 times more on prescription drugs than normal-weight men

As middle-aged men’s weight goes up, so do their monthly costs for prescription drugs to treat heart disease risk factors and weight-related conditions, according to research presented at the American Heart Association’s Scientific Sessions 2004.

8 Nov 2004

Stable weight significantly reduces risks of heart disease and development of metabolic syndrome

Gaining 15 pounds or more over several years is the major contributor to progression of risk factors for heart disease and development of metabolic syndrome, while maintaining a stable weight -- even in individuals considered obese – significantly reduces those risks, according to a study led by a Northwestern University researcher.

8 Nov 2004

Cholesterol-lowering drugs can interact with grapefruit juice and increase the risk of the drugs' potential side-effects

Britain's Medicines and Healthcare Products Regulatory Agency recently issued prescribing advice reminding healthcare professionals that certain cholesterol-lowering drugs, namely Zocor (simvastatin) and Lipitor (atorvastatin), can interact with grapefruit juice and increase the risk of the drugs' potential side-effects.

4 Nov 2004

FDA warns against use of Actra-Rx and Yilishen

The U.S. Food and Drug Administration has warned consumers not to purchase or to consume Actra-Rx or Yilishen, two products promoted and offered for sale on Web sites as "dietary supplements" for treating erectile dysfunction and enhancing sexual performance for men.

4 Nov 2004

Novel health food composition proves highly effective

A more than 50 % increase in the life span of Zucker rats, a commonly used animal model for human obesity, was seen by enrichment of unhealthy food with a novel combination of plant sterols and mineral nutrients.

4 Nov 2004

Landmark case challenges safety of Atkins diet

West Palm Beach County Court Judge Susan Lubitz ruled today that the landmark lawsuit filed by former Atkins dieter and Florida businessman Jody Gorran will go forward.

3 Nov 2004

High-dose statin therapy for aggressive cholesterol-lowering outperforms typical care

Patients treated with high doses of atorvastatin had about a one percent lower annual rate of heart attacks than similar patients receiving usual care, according to a new study in the Nov. 2, 2004 issue of the Journal of the American College of Cardiology.

2 Nov 2004

Do cholesterol-reducing drugs decrease the risk of heart attacks and strokes in diabetics?

International researchers will, for the first time, present findings from the landmark 4D trial about whether a cholesterol-reducing drug decreases the risk of heart attacks and strokes with type 2 diabetics on dialysis at the American Society of Nephrology’s 37th Annual Meeting and Scientific Exposition in St. Louis, Missouri.

1 Nov 2004

Interim recommendations on low-carb diets

From the extreme Atkins Diet to the more modest Zone Diet, low carbohydrate diets are all the rage, embraced by celebrities and the general public alike as a quick way to lose weight.

1 Nov 2004

New evidence to explain why mental function becomes less efficient with ageing

Dementia and milder forms of loss of mental ability affects millions of older people every year, but the causes are unclear. Previous research using brain scanning has shown that brain shrinkage and changes in the brain's white matter 'wiring', are associated with mental function slowing down in old age.

29 Oct 2004

DASH diet may have health benefits that go beyond lowering people's risk of heart disease

The popular DASH diet, established by the National Institutes of Health as a way to lower blood pressure and cholesterol levels, may have health benefits that go beyond its stated purpose of lowering people's risk of heart disease, according to research published in the November issue of the Journal of the American Dietetic Association.

29 Oct 2004

Cholesterol News and Research

Further Reading

Zetia co-administered with Fenofibrate significantly reduced LDL ("bad") cholesterol in mixed hyperlipidemia patients

FDA has warned consumers not to purchase or to consume Actra-Rx or Yilishen, promoted as "dietary supplements" for treating erectile dysfunction

Cranberry juice may help prevent gum disease

ACE inhibitors not needed for many heart disease patients

Generic statin drugs shown to produce similar or better results than expensive brand-name drugs

Walnut supplementation favorably affects cholesterol and other lipids that are signs of cardiovascular risk

Lipid Sciences' selective delipidation process demonstrates enhanced ability in removing cholesterol from cells

Technology to determine a patient's response to aspirin therapy taken to prevent heart attacks

Association between long-term air pollution exposure and the early stages of atherosclerosis

Obese and overweight men spend 3.5 times more on prescription drugs than normal-weight men

Stable weight significantly reduces risks of heart disease and development of metabolic syndrome

Cholesterol-lowering drugs can interact with grapefruit juice and increase the risk of the drugs' potential side-effects

FDA warns against use of Actra-Rx and Yilishen

Novel health food composition proves highly effective

Landmark case challenges safety of Atkins diet

High-dose statin therapy for aggressive cholesterol-lowering outperforms typical care

Do cholesterol-reducing drugs decrease the risk of heart attacks and strokes in diabetics?

Interim recommendations on low-carb diets

New evidence to explain why mental function becomes less efficient with ageing

DASH diet may have health benefits that go beyond lowering people's risk of heart disease

Industry Focus eBook - Analytical Chemistry (2nd Edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News